MetaCap

Who Owns Obsidian Therapeutics Stock?

NASDAQ: OBXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.00-0.15 (-1.23%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
82.50%
Institutional holders
62
  • Institutions 82.5%
  • Insiders 0.8%
  • Public and other 16.7%

Who owns Obsidian Therapeutics stock?

Institutional investors own about 82.5% of Obsidian Therapeutics's shares, spread across 62 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.81% of OBX.

The largest institutional holders are RA Capital Management, L.P. (9.64%), Atlas Venture Life Science Advisors, LLC (7.29%) and Paradigm Biocapital Advisors LP (6.73%). Together, the top 10 institutions control 50.8% of shares outstanding. In their latest filings, 10 of the top 10 institutions increased their OBX positions and 0 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of OBX

Obsidian Therapeutics top institutional holders
InstitutionShares% HeldChange
RA Capital Management, L.P.5.96M9.64%+100.0%
Atlas Venture Life Science Advisors, LLC 4.50M7.29%+100.0%
Paradigm Biocapital Advisors LP4.16M6.73%+100.0%
Novo Holdings A/S3.12M5.06%+100.0%
Trails Edge Capital Partners, LP2.50M4.04%+100.0%
Vanguard Capital Management LLC2.44M3.95%+100.0%
Octagon Capital Advisors LP2.41M3.91%+100.0%
TCG Crossover Management, LLC2.20M3.56%+100.0%
Deep Track Capital, Lp2.12M3.43%+100.0%
Citadel Advisors Llc1.95M3.15%+100.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of OBX

Obsidian Therapeutics top fund holders
FundShares% Held
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund205.48K0.33%
Fidelity Concord Street Trust-Fidelity Total Market Index Fund87.00K0.14%
Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund70.54K0.11%
iShares Trust-iShares Core S&P Total U.S. Stock Market ETF61.73K0.10%
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund34.50K0.06%
Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF16.47K0.03%

Frequently asked questions

Who is the largest shareholder of Obsidian Therapeutics?

RA Capital Management, L.P. is the largest institutional shareholder of OBX, owning 9.64% of shares outstanding (5.96M shares) as of its latest 13F filing.

What percentage of Obsidian Therapeutics is owned by institutions?

Institutions own about 82.5% of OBX shares and 83.2% of the public float.

How much of Obsidian Therapeutics do insiders own?

Insiders, such as officers and directors, own about 0.81% of OBX shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related